Tags

Type your tag names separated by a space and hit enter

Long-term oncological outcomes after laparoscopic radical prostatectomy.
BJU Int. 2013 Feb; 111(2):271-80.BI

Abstract

OBJECTIVES

To investigate long-term oncological outcomes after laparoscopic radical prostatectomy (LRP). To identify parameters influencing recurrence-free survival in a single-institution series.

PATIENTS AND METHODS

All patients underwent LRP using the transperitoneal retrograde Heilbronn technique. High-risk patients received adjuvant treatment according to an institutional algorithm based on prostate-specific antigen (PSA), Gleason score, tumour-node-metastasis stage, margin status and tumour volume. Data were collected prospectively on operative and postoperative parameters beginning in 1999. Complete follow-up data of 370 of the first 500 consecutive patients are available. Biochemical recurrence was defined as two consecutive PSA levels <0.2 ng/mL within the follow-up period. Kaplan-Meier estimates and Cox regression were applied to examine recurrence-free survival times.

RESULTS

The estimated biochemical recurrence-free survival (BCRFS) rates 10 years after LRP were 80.2% in patients staged pT2, 47.4% in those staged pT3a and 49.8% in those staged pT3b/4, confirming a better prognosis in patients with organ-confined disease (P < 0.001). In the multivariate Cox regression analysis, only Gleason score and pT stage significantly influenced BCRFS. The 10-year clinical progression-free survival rates were 97.2% (pT2), 84.4% (pT3a) and 78.1% (pT3b/4), and prostate cancer-specific survival estimates were 100% (pT2), 97.3% (pT3a) and 90.6% (pT3b/4).

CONCLUSIONS

The 10-year biochemical and clinical progression-free survival after LRP combined with a risk-adapted concept of adjuvant therapy is high, while prostate-cancer specific mortality is low. Our data shows no negative impact of laparoscopic techniques on oncologic outcomes compared to large series after retropubic radical prostatectomy. In a multivariate Cox regression, only Gleason score and pT stage had significant impact on BCRFS.

Authors+Show Affiliations

Department of Urology, SLK-Kliniken, Heilbronn, Germany. marcel.hruza@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22757970

Citation

Hruza, Marcel, et al. "Long-term Oncological Outcomes After Laparoscopic Radical Prostatectomy." BJU International, vol. 111, no. 2, 2013, pp. 271-80.
Hruza M, Bermejo JL, Flinspach B, et al. Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int. 2013;111(2):271-80.
Hruza, M., Bermejo, J. L., Flinspach, B., Schulze, M., Teber, D., Rumpelt, H. J., & Rassweiler, J. J. (2013). Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU International, 111(2), 271-80. https://doi.org/10.1111/j.1464-410X.2012.11317.x
Hruza M, et al. Long-term Oncological Outcomes After Laparoscopic Radical Prostatectomy. BJU Int. 2013;111(2):271-80. PubMed PMID: 22757970.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term oncological outcomes after laparoscopic radical prostatectomy. AU - Hruza,Marcel, AU - Bermejo,Justo Lorenzo, AU - Flinspach,Bettina, AU - Schulze,Michael, AU - Teber,Dogu, AU - Rumpelt,Hans Joachim, AU - Rassweiler,Jens Jochen, Y1 - 2012/07/03/ PY - 2012/7/5/entrez PY - 2012/7/5/pubmed PY - 2013/3/21/medline SP - 271 EP - 80 JF - BJU international JO - BJU Int VL - 111 IS - 2 N2 - OBJECTIVES: To investigate long-term oncological outcomes after laparoscopic radical prostatectomy (LRP). To identify parameters influencing recurrence-free survival in a single-institution series. PATIENTS AND METHODS: All patients underwent LRP using the transperitoneal retrograde Heilbronn technique. High-risk patients received adjuvant treatment according to an institutional algorithm based on prostate-specific antigen (PSA), Gleason score, tumour-node-metastasis stage, margin status and tumour volume. Data were collected prospectively on operative and postoperative parameters beginning in 1999. Complete follow-up data of 370 of the first 500 consecutive patients are available. Biochemical recurrence was defined as two consecutive PSA levels <0.2 ng/mL within the follow-up period. Kaplan-Meier estimates and Cox regression were applied to examine recurrence-free survival times. RESULTS: The estimated biochemical recurrence-free survival (BCRFS) rates 10 years after LRP were 80.2% in patients staged pT2, 47.4% in those staged pT3a and 49.8% in those staged pT3b/4, confirming a better prognosis in patients with organ-confined disease (P < 0.001). In the multivariate Cox regression analysis, only Gleason score and pT stage significantly influenced BCRFS. The 10-year clinical progression-free survival rates were 97.2% (pT2), 84.4% (pT3a) and 78.1% (pT3b/4), and prostate cancer-specific survival estimates were 100% (pT2), 97.3% (pT3a) and 90.6% (pT3b/4). CONCLUSIONS: The 10-year biochemical and clinical progression-free survival after LRP combined with a risk-adapted concept of adjuvant therapy is high, while prostate-cancer specific mortality is low. Our data shows no negative impact of laparoscopic techniques on oncologic outcomes compared to large series after retropubic radical prostatectomy. In a multivariate Cox regression, only Gleason score and pT stage had significant impact on BCRFS. SN - 1464-410X UR - https://www.unboundmedicine.com/medline/citation/22757970/Long_term_oncological_outcomes_after_laparoscopic_radical_prostatectomy_ L2 - https://doi.org/10.1111/j.1464-410X.2012.11317.x DB - PRIME DP - Unbound Medicine ER -